RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics, Inc.

RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics, Inc.

BILLERICA, Mass.--(BUSINESS WIRE)--

RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. ("10X") of Pleasanton, California. The suit was filed in Federal District Court in Delaware. The patents asserted are U.S. patent numbers 7129091, 822148, 8273573, 8304193, 8329407, and 889083, which are all exclusively licensed to RainDance from the University of Chicago. 10X has recently begun to offer for sale a system that infringes RainDance's patent rights, and RainDance filed this suit to vigorously defend its intellectual property and current and future products.

Complex Genetics Made Simple
RainDance Technologies offers a full product portfolio to research cell-free and cell-based biomarkers for hereditary risk predisposition, initial detection, pathology, and residual disease. The company's research-use products include:

  • RainDrop® Digital PCR System: Ultra-sensitive digital PCR system for research of early detection and monitoring of cell-free and cell-based biomarkers for cancers, viruses, pathogens, and immune disorders.
  • ThunderBolts™ Cancer Panels: 'Democratized' targeted Next-Generation Sequencing (NGS) panels enabling highly sensitive, rapid, low input, tumor profiling research in plasma, tissue and FFPE samples.
  • ThunderStorm® NGS Content Enrichment System: Industrial-scale workhorse for highly accurate, fully automated targeted NGS enrichment.

About RainDance Technologies
RainDance Technologies is making complex genetics simple. The company's ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR and ThunderStorm® Next-Generation Sequencing Content Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and ThunderStorm System in 2011. For more information, please visit www.RainDanceTech.com.

The RainDance products are for Research Use Only. Not for use in diagnostic procedures.

RainDance Technologies, the RainDance Technologies logo, RainDrop, ThunderStorm, ThunderBolts, and RainStorm are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.

Contact:

BlueChair Group
Pamela Mahoney, 408-674-6997
[email protected]

 

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.